Cargando…

Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review

BACKGROUND: Cutaneous hyperpigmentation is an often overlooked clinical sign in megaloblastic anemia (MA) which has been sporadically reported in the literature. METHODS: We describe the bone marrow (BM) changes and clinicolaboratory characteristics of 25 of 198 adult cases (>16 years) with cutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Padhi, Somanath, Sarangi, RajLaxmi, Ramdas, Anita, Ravichandran, Kandasamy, Varghese, Renu G’Boy, Alexander, Thomas, Kurian, George, Mookkappan, Sudhagar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848022/
https://www.ncbi.nlm.nih.gov/pubmed/27158434
http://dx.doi.org/10.4084/MJHID.2016.021
_version_ 1782429289287778304
author Padhi, Somanath
Sarangi, RajLaxmi
Ramdas, Anita
Ravichandran, Kandasamy
Varghese, Renu G’Boy
Alexander, Thomas
Kurian, George
Mookkappan, Sudhagar
author_facet Padhi, Somanath
Sarangi, RajLaxmi
Ramdas, Anita
Ravichandran, Kandasamy
Varghese, Renu G’Boy
Alexander, Thomas
Kurian, George
Mookkappan, Sudhagar
author_sort Padhi, Somanath
collection PubMed
description BACKGROUND: Cutaneous hyperpigmentation is an often overlooked clinical sign in megaloblastic anemia (MA) which has been sporadically reported in the literature. METHODS: We describe the bone marrow (BM) changes and clinicolaboratory characteristics of 25 of 198 adult cases (>16 years) with cutaneous hyperpigmentation who underwent BM evaluation for cytopenia (s). RESULTS: Twenty-one of 25 cases (84%) had MA, while MA without hyperpigmentation occurred only in 12 of remainder 173 cases (P<0.001). Knuckle pad hyperpigmentation (KP) was noted in 16 (64%) cases; whereas 9 (36%) had diffuse brownish black discoloration (DP) of the palms and/or soles. Eighteen of 25 (72%) cases had pancytopenia (13 with KP) and 7 of 25 (28%) had bicytopenia (3 with KP). In addition, five cases (20%) presented with pyrexia. Of the 17 cases where data available, eleven were B(12) deficient [<190 pg/ml; eight had severe deficiency (<100 pg/ml); ref.; 190–800pg/ml], while 4 had pure folate deficiency (< 4.0 ng/ml; ref.; 4–20ng/ml); and remainder 2 had combined B(12) and folate deficiency. Compared to those with diffuse pigmentation; KP group had lower Hb (69.6 ± 24.2 vs. 86.3 ± 33.9 g/L), higher MCV (106.1 ±12.6 vs. 99.2 ± 7.6 fL), lower platelet count (50.9 ± 29.3 vs. 69.6 ± 36.5 × 10(9)/L), and lower median B(12) [100.0 (30.0 – 822.0) vs. 316.0 (142.0 – 1617.3) pg/ml] (P>0.05). In six cases where follow-up data were available, there was a significant reversal of hyperpigmentation at 12 weeks following parenteral cobalamin therapy. In all five cases with pyrexia, fever subsided after 24 to 72 hours following administration of parenteral cobalamin therapy. CONCLUSION: Cutaneous hyperpigmentation and cytopenia (s) are strongly associated with megaloblastic anemia. Knuckle pad hyperpigmentation is much more frequent than diffuse pigmentation of the palms and/or soles in such patents. A nonsignificant trend towards a greater degree of MA was found in cases with pigmentation of the knuckles.
format Online
Article
Text
id pubmed-4848022
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-48480222016-05-06 Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review Padhi, Somanath Sarangi, RajLaxmi Ramdas, Anita Ravichandran, Kandasamy Varghese, Renu G’Boy Alexander, Thomas Kurian, George Mookkappan, Sudhagar Mediterr J Hematol Infect Dis Original Article BACKGROUND: Cutaneous hyperpigmentation is an often overlooked clinical sign in megaloblastic anemia (MA) which has been sporadically reported in the literature. METHODS: We describe the bone marrow (BM) changes and clinicolaboratory characteristics of 25 of 198 adult cases (>16 years) with cutaneous hyperpigmentation who underwent BM evaluation for cytopenia (s). RESULTS: Twenty-one of 25 cases (84%) had MA, while MA without hyperpigmentation occurred only in 12 of remainder 173 cases (P<0.001). Knuckle pad hyperpigmentation (KP) was noted in 16 (64%) cases; whereas 9 (36%) had diffuse brownish black discoloration (DP) of the palms and/or soles. Eighteen of 25 (72%) cases had pancytopenia (13 with KP) and 7 of 25 (28%) had bicytopenia (3 with KP). In addition, five cases (20%) presented with pyrexia. Of the 17 cases where data available, eleven were B(12) deficient [<190 pg/ml; eight had severe deficiency (<100 pg/ml); ref.; 190–800pg/ml], while 4 had pure folate deficiency (< 4.0 ng/ml; ref.; 4–20ng/ml); and remainder 2 had combined B(12) and folate deficiency. Compared to those with diffuse pigmentation; KP group had lower Hb (69.6 ± 24.2 vs. 86.3 ± 33.9 g/L), higher MCV (106.1 ±12.6 vs. 99.2 ± 7.6 fL), lower platelet count (50.9 ± 29.3 vs. 69.6 ± 36.5 × 10(9)/L), and lower median B(12) [100.0 (30.0 – 822.0) vs. 316.0 (142.0 – 1617.3) pg/ml] (P>0.05). In six cases where follow-up data were available, there was a significant reversal of hyperpigmentation at 12 weeks following parenteral cobalamin therapy. In all five cases with pyrexia, fever subsided after 24 to 72 hours following administration of parenteral cobalamin therapy. CONCLUSION: Cutaneous hyperpigmentation and cytopenia (s) are strongly associated with megaloblastic anemia. Knuckle pad hyperpigmentation is much more frequent than diffuse pigmentation of the palms and/or soles in such patents. A nonsignificant trend towards a greater degree of MA was found in cases with pigmentation of the knuckles. Università Cattolica del Sacro Cuore 2016-04-10 /pmc/articles/PMC4848022/ /pubmed/27158434 http://dx.doi.org/10.4084/MJHID.2016.021 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Padhi, Somanath
Sarangi, RajLaxmi
Ramdas, Anita
Ravichandran, Kandasamy
Varghese, Renu G’Boy
Alexander, Thomas
Kurian, George
Mookkappan, Sudhagar
Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review
title Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review
title_full Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review
title_fullStr Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review
title_full_unstemmed Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review
title_short Cutaneous Hyperpigmentation in Megaloblastic Anemia: a Five Year Retrospective Review
title_sort cutaneous hyperpigmentation in megaloblastic anemia: a five year retrospective review
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848022/
https://www.ncbi.nlm.nih.gov/pubmed/27158434
http://dx.doi.org/10.4084/MJHID.2016.021
work_keys_str_mv AT padhisomanath cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT sarangirajlaxmi cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT ramdasanita cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT ravichandrankandasamy cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT vargheserenugboy cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT alexanderthomas cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT kuriangeorge cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview
AT mookkappansudhagar cutaneoushyperpigmentationinmegaloblasticanemiaafiveyearretrospectivereview